Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | PTGIR | P43119 | 2/20 | 0.49 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9681651 | 0.91 | HPGD (0.58) | ALDH1A1SMN1; SMN2HPGDTSHRMAPK1 | |
| SCHEMBL9681617 | 0.90 | HPGD (0.57) | ALDH1A1SMN1; SMN2HPGDL3MBTL1TP53 | |
| SCHEMBL18883164 | 0.88 | ALDH1A1 (0.67) | ALDH1A1SMN1; SMN2HPGDTSHRMAPK1 | |
| SCHEMBL9680468 | 0.83 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2HPGDTSHRMAPK1 | |
| SCHEMBL18883184 | 0.82 | HRH3 (0.47) | ALDH1A1SMN1; SMN2HPGDTSHRMAPK1 | |
| SCHEMBL20305916 | 0.81 | ELANE (0.44) | ALDH1A1SMN1; SMN2HPGDTSHRMAPK1 | |
| SCHEMBL20305915 | 0.80 | ABCB1 (0.45) | ALDH1A1SMN1; SMN2HPGDTSHRMAPK1 | |
| SCHEMBL9681715 | 0.80 | NPSR1 (0.54) | ALDH1A1SMN1; SMN2HPGDTSHRMAPK1 | |
| SCHEMBL9679674 | 0.79 | ALDH1A1 (0.75) | ALDH1A1SMN1; SMN2HPGDTSHRMAPK1 | |
| SCHEMBL11263701 | 0.79 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2HPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005851-B2 | Polymerization initiator and radically polymerizable composition containing same | ADEKA CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-10005851-B2 | Polymerization initiator and radically polymerizable composition containing same | ADEKA CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-20170145121-A1 | NOVEL POLYMERIZATION INITIATOR AND RADICALLY POLYMERIZABLE COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2017-05-25 | — | — | US | disclosed |
| US-20170145121-A1 | NOVEL POLYMERIZATION INITIATOR AND RADICALLY POLYMERIZABLE COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145121-A1 | NOVEL POLYMERIZATION INITIATOR AND RADICALLY POLYMERIZABLE COMPOSITION CONTAINING SAME | CYBA, CCNT1, CCNA1 | ALDH1A1 269/4885SMN1; SMN2 2012/4885HPGD 2887/4885 |
| US-10005851-B2 | Polymerization initiator and radically polymerizable composition containing same | CYBA, CCNT1, SPTBN1 | ALDH1A1 165/4885SMN1; SMN2 1607/4885HPGD 2839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.